Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golidocitinib + CHOP in newly diagnosed PTCL
NCT06739265Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of golidocitinib in peripheral T-cell lymphoma (PTCL), sponsored by Peking Union Medical College Hospital. Started Sep 2024; status: recruiting.
02
Drugs
golidocitinib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT06739265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06739265.